2015
DOI: 10.1097/mou.0000000000000160
|View full text |Cite
|
Sign up to set email alerts
|

In-bore MRI interventions

Abstract: Advances in multiparametric-MRI has opened up opportunities for in-bore targeted focal treatment of PCa in the correctly selected patient.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2015
2015
2018
2018

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 9 publications
(2 citation statements)
references
References 67 publications
(72 reference statements)
0
2
0
Order By: Relevance
“…With a rising PSA, standard protocol is a 12-core systematic TRUS biopsy [ 5 ], which is not an option for our patient because of his IPAA. Advances in prostate MP-MRI in characterizing suspicious lesions and the advent of software platforms like Visualase [ 6 , 7 ] allowed us our first ever in-bore MRI-guided transperineal prostate biopsy with no TRUS of a UC patient with IPAA.…”
Section: Discussionmentioning
confidence: 99%
“…With a rising PSA, standard protocol is a 12-core systematic TRUS biopsy [ 5 ], which is not an option for our patient because of his IPAA. Advances in prostate MP-MRI in characterizing suspicious lesions and the advent of software platforms like Visualase [ 6 , 7 ] allowed us our first ever in-bore MRI-guided transperineal prostate biopsy with no TRUS of a UC patient with IPAA.…”
Section: Discussionmentioning
confidence: 99%
“…[ 15 ] Visualization of tumor allows in-bore MR-guided focal treatment to be more suitable for targeted ablation and accurate targeting without any misregistration concerns. [ 37 ] In-bore treatment also offers the advantage of MR thermometry, which provides real-time monitoring of the thermal map during the treatment to ensure selective and adequate tumor ablation and preservation of sensitive surrounding structures. Contrast-enhanced scan at the end of the procedure shows the non-perfused volume and helps confirm adequate treatment coverage before the patient is taken off the table.…”
Section: Introductionmentioning
confidence: 99%